Zydus gets US FDA final approval for Ivabradine Tablets, 5 mg and 7.5 mg
Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Pharma contract manufacturing sees historic surge amidst inflation and investment challenges:…
The total commercial dose contract manufacturing organisation (CMO) contract revenue year-on-year (YoY) soared by an impressive…
Enzene Biosciences launches Ranibizumab to treat neovascular AMD
Ranibizumab biosimilar is the company’s seventh biosimilar
Investment in novel therapies key priority to tackle AMR: GlobalData
As per GlobalData Pharmaceutical Intelligence Center’s pipeline drugs database, there are around 929 antibiotics and 182…
Sanjivani Paranteral, Hindustan Antibiotics partner to manufacture IV formulations and IV Sets
The partnership will see the establishment of a manufacturing facility within the premises of Hindustan Antibiotics at Pimpri…
Experts believe gene therapies will disrupt Gaucher disease drug market: GlobalData
Gaucher disease, a rare inherited metabolic disorder caused by defects in the GBA1 gene, results in harmful glucocerebroside…
Strides gets USFDA approval for generic Suprep Bowel Prep Kit
The product belongs to a group of medicines prescribed to those who are required to undergo a colon cleanse prior to a colonoscopy
Lupin launches FDC drug Vilfuro-G for COPD management in India
The launch follows the approval granted by the Drug Controller General of India for the dry powder inhaler (DPI) product
Evive, Acrotech get FDA nod for Ryzneuta (Efbemalenograstim alfa Injection) for chemo-induced…
Neutropenia is characterised by persistently low levels of neutrophils due to the use of chemotherapy and other types of…
Lupin gets US FDA approval for Dapagliflozin tablets and Pitavastatin tablets
Both the products will be manufactured at Lupin’s Pithampur facility in India
Strides gets USFDA approval for Levetiracetam Oral Solution
It is used in the treatment of seizures
Sugemalimab approval in China makes it only second drug approved globally for ENKTL: GlobalData
GlobalData forecasts sugemalimab to generate sales of $31 million (patient-based forecast) by 2030 for T-cell lymphomas in China
Dr Reddy’s rolls out Nerivio, drug-free non-invasive migraine management device, in India
Nerivio is the first and only USFDA approved device to use Remote Electrical Neuromodulation (REN) to prevent and treat migraine
Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData
The global cell and gene therapy market is expected to reach $80 billion in 2029, with a high CAGR of 51.6 per cent between 2023…
Verve’s gene-editing therapy trial to lower cholesterol levels opens doors for use in CVDs:…
PCSK9 inhibitors, like VERVE-101, currently holds 20 per cent market share in the acute coronary syndrome market. PCSK9 inhibitors…
Glenmark’s La Shield gets Best Consumer Healthcare Digital Marketing Campaign Award
The campaign ‘Be Sun wise’ leveraged the available online information through dynamic creative optimisation to provide consumers…
NPPA slashes prices on 33 FDCs drugs
This move affects pharma companies like JB Chemicals, Eris Lifesciences, Zydus Healthcare, Cipla, Sun Pharma, Sanofi India, and…
Biocon Biologics gets MHRA approval for YESAFILI, biosimilar Aflibercept
In September, YESAFILI received marketing authorisation approval from the European Commission (EC) for the European Union (EU)
First-in-class DLL3-targeting BiTE could be the next big player in SCLC treatment: GlobalData
The drug is forecast to achieve peak sales of $788 million by 2029
Zydus NCE drugs will see improved market penetration with new partnerships in India: GlobalData
Zydus Lifesciences recently entered into a co-marketing partnership with Sun Pharma for desidustat for anemia associated with CKD…